DRREDDY Dr Reddy's Laboratories Ltd Company Mergers Announcement 2024 - Acquisition Update Dr. Reddys Laboratories has invested USD 620 million in preference shares of its wholly-owned subsidiary, Dr. Reddys Laboratories SA, for the acquisition of Nicotinell and related brands from Haleon Group, with DRL SAs turnover for CY2023 being USD 392 million..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Dr Reddy's Laboratories Ltd